Transport of free 211At and 125I- in thyroid epithelial cells: effects of anion channel blocker 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid on apical efflux and cellular retention

Nuclear Medicine and Biology

Volumn 34, Issue 5, 2007, Pages 523-530

  Lindencrona, Ulrika ^a   Forssell Aronsson, Eva ^a   Nilsson, Mikael ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Astatine; Efflux; EGF; Iodine; Thyroid

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ASTATINE 211; BLOCKING AGENT; EPIDERMAL GROWTH FACTOR; FORSKOLIN; IODINE 125; ION CHANNEL; THYROTROPIN; ANTIPORTER; ASTATINE; COTRANSPORTER; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; SODIUM IODIDE SYMPORTER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; CELL TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG SENSITIVITY; DRUG TRANSPORT; EPITHELIUM CELL; NONHUMAN; PHARMACOLOGICAL BLOCKING; RADIOBIOLOGY; RADIOCHEMISTRY; SWINE; THYMOCYTE; THYROID CELL; TRANSPORT KINETICS; ACTIVE TRANSPORT; ANIMAL; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; METABOLIC CLEARANCE RATE; METABOLISM; PHYSIOLOGY; THYROID GLAND;

4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID; ANIMALS; ANTIPORTERS; ASTATINE; BIOLOGICAL TRANSPORT, ACTIVE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; IODINE RADIOISOTOPES; METABOLIC CLEARANCE RATE; RADIOPHARMACEUTICALS; SWINE; SYMPORTERS; THYROID GLAND;

EID: 34250754525     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.03.012     Document Type: Article

References (34)

1. Spitzweg C., Harrington K.J., Pinke L.A., Vile R.G., and Morris J.C. The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 86 (2001) 3327-3335
2. Chung J. Sodium iodide symporter: Its role in nuclear medicine. J Nucl Med 43 (2002) 1188-1200
3. - symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol 213 (2003) 59-70
4. - symporter (NIS): imaging and therapeutic applications. Semin Nucl Med 34 (2004) 23-31
5. Riesco-Eizaguirre G., and Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 155 (2006) 495-512
6. - symporter gene. Endocrinology 138 (1997) 4493-4496
7. Haberkorn U., Kinscherf R., Kissel M., Kübler W., Mahmut M., Sieger S., et al. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose. Gene Ther 10 (2003) 774-780
8. 125I ion transport in porcine thyroid epithelial cells cultured in bicameral chamber. Nucl Med Biol 28 (2001) 41-50
9. 211At]astatide in NIS-transfected human cancer cells. Nucl Med Biol 29 (2002) 729-739
10. 131I-iodide to glioma tumor cells expressing the sodium/iodide symporter. J Nucl Med 44 (2003) 1827-1838
11. Petrich T., Helmeke H.J., Meyer G.J., Knapp W.H., and Potter E. Establishment of radioactive astatine and iodine uptake in cancer cell line expressing the human sodium/iodide symporter. Eur J Nucl Med Mol Imaging 29 (2002) 842-854
12. 211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors. Clin Cancer Res 12 (2006) 1342-1348
13. ICRU. Stopping powers and ranges for protons and alpha particles. ICRU Report 49 (1993), International Commission on Radiation Units and Measurements, Bethesda (Md)
14. Nilsson M., Björkman U., Ekholm R., and Ericson L.E. Iodide transport in primary cultured thyroid follicle cells: evidence of a TSH-regulated channel mediating iodide efflux selectively across the apical domain of the plasma membrane. Eur J Cell Biol 52 (1990) 270-281
15. Scott D.A., Wang R., Kreman T.M., Sheffield V.C., and Karniski L.P. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet 21 (1999) 440-443
16. Bidart J.M., Mian C., Lazar V., Russo D., Filetti S., Caillou B., et al. Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J Clin Endocrinol Metab 85 (2000) 2028-2033
17. Yoshida A., Taniguchi S., Hisatome I., Royaux I.E., Green E.D., Kohn L., et al. Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells. J Clin Endocrinol Metab 87 (2002) 3356-3361
18. Gillam M.P., Sidhaye A.R., Lee E.J., Rutishauser J., Stephan C.W., and Kopp P. Functional characterization of pendrin in a polarized cell system. Evidence for pendrin-mediated apical iodide efflux. J Biol Chem 279 (2004) 13004-13010
19. Rodriguez A.M., Perron B., Lacroix L., Caillou B., LeBlanc G., Schlumberger M., et al. Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab 87 (2002) 3500-3503
20. Lacroix L., Pourcher T., Magnon C., Bellon N., Talbot M., Intaraphairot T., et al. Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters. J Clin Endocrinol Metab 89 (2004) 1423-1428
21. Amphoux-Fazekas T., Samih N., Hovsépian S., Aouani A., Beauwens R., and Fayet G. DIDS (4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid) increases iodide trapping, inhibits thyroperoxidase and antagonizes the TSH-induced apical iodide efflux in porcine thyroid cells. Mol Cell Endocrinol 141 (1998) 129-140
22. Lindegren S., Bäck T., Jacobsson L., Karlsson B., and Skarnemark G. Dry-distillation from irradiated bismuth targets: a time-saving procedure with high recovery yields. Appl Radiat Isot 55 (2001) 157-160
23. Nilsson M., Björkman U., Ekholm R., and Ericson L.E. Polarized efflux of iodide in porcine thyrocytes occurs via a cAMP-regulated iodide channel in the apical plasma membrane. Acta Endocrinol 126 (1992) 67-74
24. Nilsson M., and Ericson L.E. Effects of epidermal growth factor on basolateral iodide uptake and apical iodide permeability in filter-cultured thyroid epithelium. Endocrinology 135 (1994) 1428-1436
25. Cobb L.M., Harrison A., Dudley N.E., Carr T.E.F., and Humphreys J.A. Relative concentration of astatine-211 and iodine-125 by human fetal thyroid and carcinoma of the thyroid in nude mice. Radiother Oncol 13 (1989) 203-209
26. 211At-biomolecules. Radiochim Acta 47 (1989) 143-147
27. Ericson L.E., and Nilsson M. Effects of insulin-like growth factor I on growth, epithelial barrier and iodide transport in polarized pig thyrocyte monolayers. Eur J Endocrinol 135 (1996) 118-127
28. Vasáros L., and Berei K. General properties of astatine. In: Kugler H.K., and Keller C. (Eds). Gmelin handbook of inorganic chemistry - astatine. 8th ed (1985), Springer-Verlag, Berlin 107-128
29. -. Appl Radiat Isot 62 (2005) 395-403
30. Kogai T., Endo T., Saito T., Miyazaki A., Kawaguchi A., and Onaya T. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138 (1997) 2227-2232
31. Kopp P. Pendred's syndrome: identification of the genetic defect a century after its recognition. Thyroid 9 (1999) 65-69
32. Fitz J.G., Basavappa S., McGill J., Melhus O., and Cohn J.A. Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest 91 (1993) 319-328
33. Devuyst O., Golstein P.E., Sanches M.V., Piontek K., Wilson P.D., Guggino W.B., et al. Expression of CFTR in human and bovine thyroid epithelium. Am J Physiol 272 (1997) C1299-C1308
34. Elisei R., Vivaldi A., Ciampi R., Faviana P., Basolo F., Santini F., et al. Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid. J Clin Endocrinol Metab 91 (2006) 2389-2395